Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Share News

DIRECTOR DEALINGS: AJ Bell and PetroTal CEOs and Astra CFO sell shares

19th Aug 2025 11:54

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Monday and Tuesday and not separately reported by Alliance News: Read More

LONDON MARKET CLOSE: FTSE 100 pushes higher as US rate cut bets build

13th Aug 2025 16:56

(Alliance News) - The FTSE 100 made steady progress on Wednesday, pushing back towards record highs, as hopes grew that the US Federal Reserve will lower interest rates in the coming months. Read More

PRESS: Rolls-Royce CEO rules out US listing amid high hopes for SMRs

13th Aug 2025 12:53

(Alliance News) - Rolls-Royce Holding PLC's plan to power artificial intelligence with its small nuclear reactors could make it the UK's most valuable company, its chief executive told the BBC. Read More

LONDON MARKET MIDDAY: Mixed trade but mood "relaxed" on US-China talks

11th Aug 2025 12:07

(Alliance News) - London's FTSE 100 outperformed on Monday, sitting solidly higher in afternoon dealings, though stocks in mainland Europe faded. Read More

LONDON MARKET MIDDAY: Pound climbs after BoE cut in knife-edge vote

7th Aug 2025 12:12

(Alliance News) - London's FTSE was on the decline on Thursday afternoon, while the pound moved above the USD1.34 mark, after the Bank of England cut rates in a decision that needed a second vote. Read More

LONDON BROKER RATINGS: Jefferies lifts BAE Systems; HSBC cuts Shell

4th Aug 2025 09:37

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday: Read More

LONDON MARKET CLOSE: Stocks rocked by tariffs and weak US jobs print

1st Aug 2025 16:54

(Alliance News) - The FTSE 100 sank on Friday after US President Donald Trump announced tariffs on dozens of trading partners, and weak US jobs data fuelled concerns as to the strength of the US economy. Read More

UK dividends calendar - next 7 days

31st Jul 2025 14:24

Read More

LONDON BROKER RATINGS: Deutsche cuts Rio Tinto; Kepler raises Unite

31st Jul 2025 10:05

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday: Read More

LONDON MARKET CLOSE: FTSE 100 ends flat ahead of likely Fed rate hold

30th Jul 2025 16:56

(Alliance News) - The FTSE 100 struggled for direction on Wednesday, despite progress elsewhere, as investors digested another earnings deluge and looked ahead to the US rate call and earnings from technology titans Meta Platforms and Microsoft. Read More

LONDON BROKER RATINGS: JPMorgan raises Croda; Peel Hunt cuts Ferrexpo

30th Jul 2025 10:10

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday: Read More

LONDON MARKET CLOSE: FTSE 100 climbs as earnings cascade brings cheer

29th Jul 2025 17:13

(Alliance News) - The FTSE 100 made strong progress on Tuesday boosted by results from AstraZeneca and Barclays, but it was gloomy day for investors in Novo Nordisk. Read More

LONDON MARKET MIDDAY: European stocks rise as eyes on US-China talks

29th Jul 2025 12:18

(Alliance News) - The FTSE 100 was higher at midday on Tuesday, boosted by well-received earnings, while peers in Europe were back on the up after struggling at the start of the week as Monday's initial lift from a US-EU trade agreement proved short-lived. Read More

LONDON MARKET OPEN: FTSE 100 rises on lift from AstraZeneca results

29th Jul 2025 09:18

(Alliance News) - Stock prices in London opened mixed on Tuesday, as an earnings boost at AstraZeneca was well received by investors and supported the blue-cap index. Read More

AstraZeneca second quarter sales and profit boosted by cancer drugs

29th Jul 2025 08:56

(Alliance News) - AstraZeneca PLC on Tuesday reported better-than-expected second quarter revenue, and raised its dividend, boosted by strong sales from its cancer portfolio. Read More

LONDON BRIEFING: AstraZeneca earnings increase; Greggs profit sinks

29th Jul 2025 07:50

(Alliance News) - AstraZeneca raised its dividend as drug growth pushed earnings higher, Barclays launched a new buyback programme after profit jumped while Greggs saw profit fall despite higher sales. Read More

AstraZeneca's Imfinzi granted priority review for cancer forms in US

28th Jul 2025 08:25

(Alliance News) - AstraZeneca PLC on Monday said the US Food & Drug Administration has granted priority review for its immunotherapy drug Imfinzi for some cancer forms. Read More

AstraZeneca receives positive opinion from EMA for COPD therapy

25th Jul 2025 12:15

(Alliance News) - AstraZeneca PLC on Friday said its therapy for the treatment of chronic obstructive pulmonary disease in adults has received a positive opinion from the European Medicines Agency. Read More

AstraZeneca hails gefurulimab trial results on myasthenia gravis

24th Jul 2025 14:10

(Alliance News) - AstraZeneca PLC on Thursday said its investigational complement C5 inhibitor gefurulimab showed statistically significant results in treating adults with a form of generalised myasthenia gravis, an autoimmune neuromuscular disease. Read More

LONDON MARKET CLOSE: FTSE 100 hits new high on US trade talk optimism

23rd Jul 2025 17:04

(Alliance News) - European stocks climbed on Wednesday, boosted by hopes of further progress in trade talks after the US struck a deal with Japan. Read More

FTSE 100 Latest
Value9,288.14
Change98.92